Episode Details

Back to Episodes
Vuelta a España Check-In: How is Equipo Kern Pharma Outperforming WorldTour Teams?

Vuelta a España Check-In: How is Equipo Kern Pharma Outperforming WorldTour Teams?

Published 1 year, 7 months ago
Description
Spencer Martin of the Beyond the Peloton Newsletter and Andrew Vontz of the Choose the Hard Way Podcast/The Better Lab break down the ongoing Vuelta a España, how a small second-division team is better at finding talent than Ineos, and if Primož Roglič will win his fourth career overall title.
BTP In-Depth Daily Vuelta a España Breakdowns
Listen to Andrew's Choose the Hard Way Podcast
BTP is seamlessly following every twist and turn of the 2024 Tour de France with the fantastic Tour Tracker app (iPhone/Android/Web)
Hit up Andrew (@vontz) on Twitter/X & Spencer (@spencersoward) on Threads with your questions, opinions, and anything else cycling-related

This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit beyondthepeloton.substack.com/subscribe
Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us